News

SORT BY YEAR
19 August, 2021

Ally Bridge Portfolio News – Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, Aug. 18, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission’s ongoing regulatory review. Illumina, the global […]

Read More
4 August, 2021

Ally Bridge Portfolio News – Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases

Sonoma Biotherapeutics’ platform and product candidates aim to restore immune system balance through complementary regulatory T cell (Treg) therapy and effector T cell (Teff) conditioning Series B financing comprised of strong syndicate of leading life science investors Financing supports the advancement of Sonoma Bio’s Treg therapy platform, a novel Teff conditioning therapy and the build-out of a […]

Read More
16 July, 2021

Ally Bridge Portfolio News – Rapid Micro Biosystems Announces Pricing of Initial Public Offering

July 14, 2021 21:30 ET | Source: Rapid Micro Biosystems, Inc. LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the pricing of its initial […]

Read More
16 July, 2021

Ally Bridge Portfolio News – Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care

Imperative Care to Create Strategic Network of Wholly Owned Development Subsidiaries in Areas of Synergy, Starting with Acquisition of Truvic Medical, Inc., a Peripheral Thrombectomy Innovator July 15, 2021 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners […]

Read More
28 June, 2021

CMR Surgical raises $600 million in Series D financing, led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group

June 28, 2021 07:00 ET | Source: CMR Surgical Funding fully supports the accelerated continued global expansion and commercial scale up of the business Financing round led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group The largest ever MedTech private financing round worldwide to help bring Versius® to hospitals around the worldi CAMBRIDGE, UK – 28 June 2021, 07:01 (BST). CMR Surgical (CMR or “the Company”), a global surgical robotics business, today announces […]

Read More
5 June, 2021

Ally Bridge Portfolio News – GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test

— Galleri’s ability to detect more than 50 types of cancer with a single blood draw could transform early cancer detection as a complement to existing screenings; test now available in U.S. by prescription only — MENLO PARK, Calif., June 4, 2021 — GRAIL, Inc., a healthcare company whose mission is to detect cancer early, […]

Read More
6 May, 2021

Ally Bridge Portfolio News – Vida Health raises $110M in Series D round led by General Atlantic, Centene, and AXA Venture Partners

New capital to help Vida continue to scale virtual chronic mental and physical healthcare services after tripling revenue in 2020 Led by General Atlantic, the $110M Series D fundraise will help Vida continue to expand its network of providers, deepen its machine learning capabilities, broaden its commercial efforts, and provide more people the care they […]

Read More
28 April, 2021

Ally Bridge Portfolio News – Ultivue Announces $50M Financing Round

April 27, 2021 10:07 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE) –Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue phenotyping, today announced the completion of a $50 million Series D round of financing. New investors include Ally Bridge Group, Pura Vida […]

Read More
16 March, 2021

Ally Bridge Portfolio News – Rapid Micro Biosystems Raises $81M to Continue Global Expansion of Automated Pharmaceutical QC Platform to Improve Data Integrity and Safety in Biologics, Vaccines, and Cell & Gene Therapy Manufacturing

LOWELL, Mass., March 16, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc., the leading provider of data integrity and automation technology for microbial detection in biopharmaceutical manufacturing, today announced the completion of an $81 million equity financing. The funding round was led by new investor D1 Capital Partners, along with funds and accounts managed by […]

Read More
3 March, 2021

RefleXion Adds Ally Bridge Group to Investor Syndicate

Expands Series D financing by $40M March 02, 2021 10:00 AM Eastern Standard Time HAYWARD, Calif.–(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the successful completion of a $40 million extension to its Series D financing, which combined with $110 million raised […]

Read More